Objective: To evaluate marijuana use by adolescents and young adults with inflammatory bowel disease (IBD). Study design: This descriptive cross-sectional study of patients seen between December 2015 through June 2017 at Children's Hospital Colorado for IBD enrolled patients 13-23 years of age, independent of marijuana use status. Information obtained consisted of chart review, electronic and interview self-report, and serum cannabinoid levels. Marijuana ever-users were compared with never-users for clinical characteristics and perceptions of risk with use; users provided information on routes, patterns, motivations, and perceived benefits and problems with use. Results: Of 99 participants, ever-use was endorsed by 32% (32 of 99) and daily or almost daily use by 9% (9 of 99). Older age was the only characteristic related to endorsing marijuana use. Twenty-nine ever-users completed all questionnaires. After adjusting for age, users were 10.7 times more likely to perceive low risk of harm with regular use (P
CITATION STYLE
Hoffenberg, E. J., McWilliams, S. K., Mikulich-Gilbertson, S. K., Murphy, B. V., Lagueux, M., Robbins, K., … Hopfer, C. J. (2018). Marijuana Use by Adolescents and Young Adults with Inflammatory Bowel Disease. Journal of Pediatrics, 199, 99–105. https://doi.org/10.1016/j.jpeds.2018.03.041
Mendeley helps you to discover research relevant for your work.